|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.90 NOK | +0.87% |
|
-4.30% | -18.91% |
| 06-09 | Photocure, Artera Enter Research Partnership for Bladder Cancer Diagnostics | MT |
| 06-08 | Photocure ASA and Artera Partner on Digital Pathology AI Test Evaluation for Bladder Cancer | CI |
| Market Cap | 1.54B 163M 140M 129M 121M 225M 15.58B 230M 1.53B 596M 7.51B 611M 598M 25.93B | P/E Ratio 2026 * |
19x | P/E Ratio 2027 * | 30.2x |
|---|---|---|---|---|---|
| Enterprise Value | 1.22B 129M 111M 102M 95.74M 178M 12.31B 182M 1.21B 471M 5.94B 483M 472M 20.49B | EV / Sales 2026 * |
1.92x | EV / Sales 2027 * | 1.74x |
| Free-Float |
94.52% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Photocure ASA
| 1 day | +0.87% | ||
| 1 week | -4.30% | ||
| Current month | -6.61% | ||
| 1 month | -9.67% | ||
| 3 months | -17.76% | ||
| 6 months | -12.93% | ||
| Current year | -18.91% |
| 1 week | 56.2 |  | 63.5 |
| 1 month | 56.2 | | 67.8 |
| Current year | 55.2 | | 79.8 |
| 1 year | 49.5 | | 79.8 |
| 3 years | 40.7 | | 79.8 |
| 5 years | 40.7 | | 151.5 |
| 10 years | 21.5 | | 154.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel Schneider
CEO | Chief Executive Officer | - | 2018-10-31 |
Erik Dahl
CEO | Chief Executive Officer | - | 2018-06-30 |
Anders Neijber
CTO | Chief Tech/Sci/R&D Officer | - | 2021-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Neal Shore
BRD | Director/Board Member | - | 2021-12-31 |
Dylan Hallerberg
CHM | Chairman | - | 2023-09-26 |
| Director/Board Member | - | 2024-05-22 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25-04-01 | Buy | Company | 8,997 | 0.0332% | ||
| 25-04-01 | Buy | Company | 11,355 | 0.0419% | ||
| 25-03-30 | Buy | Company | 27,113 | 0.1000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.87% | -4.30% | +11.13% | +15.11% | 161M | |
| +2.16% | +7.62% | +43.83% | +160.28% | 1,013B | |
| -0.07% | +6.76% | +52.34% | +48.95% | 574B | |
| -0.08% | +3.52% | +18.61% | +62.66% | 397B | |
| +0.77% | +4.97% | +21.24% | +15.95% | 324B | |
| +0.85% | +2.79% | +24.89% | +15.93% | 280B | |
| +2.10% | +7.06% | +24.57% | +34.79% | 273B | |
| +4.84% | +4.68% | +20.66% | +61.85% | 182B | |
| -0.19% | +3.96% | -45.64% | -48.23% | 194B | |
| +3.61% | -2.42% | +14.33% | +61.12% | 151B | |
| Average | +0.86% | +1.87% | +18.60% | +42.84% | 338.88B | |
| Weighted average by Cap. | +0.44% | +3.99% | +29.35% | +72.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 634M 67.02M 57.78M 53.13M 49.89M 92.76M 6.42B 94.86M 631M 245M 3.09B 252M 246M 10.68B | 676M 71.35M 61.52M 56.56M 53.12M 98.76M 6.83B 101M 671M 261M 3.29B 268M 262M 11.37B |
| Net income | 81.5M 8.61M 7.42M 6.82M 6.41M 11.92M 824M 12.18M 80.99M 31.51M 397M 32.31M 31.62M 1.37B | 51M 5.39M 4.64M 4.27M 4.01M 7.46M 516M 7.62M 50.68M 19.72M 249M 20.22M 19.78M 858M |
| Net Debt | -323M -34.12M -29.41M -27.04M -25.4M -47.22M -3.27B -48.29M -321M -125M -1.57B -128M -125M -5.44B | -365M -38.55M -33.24M -30.56M -28.7M -53.36M -3.69B -54.57M -363M -141M -1.78B -145M -142M -6.14B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-11 | 57.90 kr | +0.87% | 31,364 |
| 26-06-10 | 57.40 kr | 0.00% | 102,319 |
| 26-06-09 | 57.40 kr | -1.37% | 60,795 |
| 26-06-08 | 58.20 kr | -1.19% | 58,011 |
| 26-06-05 | 58.90 kr | -3.28% | 146,769 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PHO Stock
Select your edition
All financial news and data tailored to specific country editions
